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Abstract
Background: Pseudomonas oryzihabitans is a Pseudomonas bacterial organism rarely implicated in human infections. The
bacterium has been isolated in a few reported cases of neurosurgical infections and patients with end-stage cirrhosis,
sickle cell disease, and community-acquired urinary tract infections. Limited information exists in developing countries,
however, because of the lack of advanced microbiological tools for identification and characterization of this bacterium.
This case report describes the isolation of a rare Pseudomonas bacterium in a patient presenting with sepsis and skin
infection.
Case presentation: A 1-year-old girl was presented to a hospital in the northeastern part of Ghana with a 1-week history
of pustular rashes on her scalp and neck, which occasionally ruptured, along with discharge of yellowish purulent fluid.
The child is of Mole-Dagbon ethnicity and hails from the northern part of Ghana. Pseudomonas oryzihabitans was
identified in the patient’s blood culture using the 16S ribosomal deoxyribonucleic acid sequencing technique. The rash
on the patient’s scalp and skin resolved after continuous treatment with gentamicin while her condition improved
clinically.
Conclusions: This finding suggests the potential of this bacterium to cause disease in unsuspected situations and
emphasizes the need to have evidence for the use of the appropriate antibiotic in clinical settings, particularly in rural
settings in Africa. It also brings to the fore the unreliability of conventional methods for identification of Pseudomonas
bacteria in clinical samples and thus supports the use of 16S ribosomal deoxyribonucleic acid in making the diagnosis.
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Background
Pseudomonas oryzihabitans is the current name of a
non-lactose-fermenting bacterium that used to be called
Chromobacterium typhiflavum and Flavimonas oryziha-
bitans [1]. The species name typhiflavum was originally
described by Dressel and Stickl as a variant of typhoid
bacillus [2]. The bacterium is gram-negative and oxi-
dase-negative with typical yellow-pigmented colonies visu-
alized on agar media. It is thought to survive in moist
environments, especially rice paddies, although some
researchers have cultured cases from inhalational therapy
equipment and hospital sinks [3, 4]. The organism has
rarely been implicated as pathogenic in humans and often
is not given serious attention in clinical practice.
Since the 1970s, when the first case of bacteremia in a
neurosurgical patient with extradural cerebral hemorrhage
secondary to P. oryzihabitans was reported, other re-
searchers have identified the pathogen in patients with can-
cer, end-stage cirrhosis, sickle cell disease, and community-
acquired urinary tract infections [5, 6]. P. oryzihabitans,
unlike the other forms of Pseudomonas bacteria (for ex-
ample, Pseudomonas aeruginosa, and Burkholderia cepa-
cia) is susceptible to quinolones, carbapenems, β-
lactamase inhibitor drugs, and trimethoprim/sulfameth-
oxazole [4, 7]. Treatment algorithms for managing P.
oryzihabitans are not available in Ghana and many other
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developing countries, particularly those in sub-Saharan Af-
rica. We report a case that is of significance because of the
rare occurrence of this pathogen, the unique microbial
characteristics of the bacteria, the age of the child involved,
and the consequential clinical outcome.
Case presentation
A 1-year-old girl was presented to a hospital in the
northeastern part of Ghana with a 1-week history of
pustular rashes on her scalp and neck, which occa-
sionally ruptured, along with discharge of yellowish
purulent fluid. The child is of Mole-Dagbon ethnicity
and hails from the northern part of Ghana. The pa-
tient had also experienced recurrent episodes of fever
for 3 days, which had been controlled with the use of
acetaminophen. The child had no known history of
human immunodeficiency virus (HIV) infection, tu-
berculosis, or other underlying medical condition and
lived with her parents, whose primary occupation was
farming. The child lives in a rural area about 20 km
from the hospital. On examination, the patient
weighed 8 kg, was pale and febrile with a temperature
of 39.7 °C, and well-hydrated. Her heart rate was 132
beats per minute, and her heart sounds were normal. Her
lungs were clear, and her respiratory rate was 35 breaths
per minute. A provisional diagnosis of sepsis and malaria
was made.
Pending the results of laboratory tests of collected
blood, urine, and stool samples, the patient was empiric-
ally treated with 270 mg of intravenous cefuroxime three
times daily and 40 mg of intravenous gentamicin daily
for 48 hours. Intravenous artesunate 24 mg was also
administered for the first 24 hours (Table 1).
Complete blood count investigations showed a
hemoglobin concentration of 6.6 g/dl and a total white
blood cell count of 8800 cells/μl (lymphocytes 52.1%,
neutrophils 37.4%). The result of a malaria rapid diag-
nostic test was positive for malaria. The patient was
given a hemotransfusion of 240 ml of whole blood over
a period of 4 hours.
Results of both urine and stool cultures were negative
for any bacterial growth. The blood culture sample was
flagged as positive after 24 hours of incubation in an au-
tomated BD BACTEC 9050 blood culture system (BD
Biosciences, San Jose, CA, USA), and a Gram stain of
the culture broth revealed gram-negative rods. The
broth was subcultured on blood agar, chocolate agar,
and MacConkey agar (Oxoid Ltd, Basingstoke, UK) and
incubated at 37 °C and 30 °C. Growth characteristics at
37 °C were poor, with grayish nonhemolytic colonies on
blood agar and nonlactose fermentation on MacConkey
agar. Plates incubated at 30 °C showed good pure growth
on MacConkey agar and nonhemolytic colonies on blood
agar. Results of biochemical investigations were negative
for oxidase and urease and positive for citrate. The isolate
was subjected to analytical profile index (API) 20NE and
20E (bioMérieux, Marcy-l’Étoile, France), which yielded
unacceptable results.
Molecular identification was performed by extracting
deoxyribonucleic acid (DNA) from a pure culture of this
bacterium using SpheroLyse DNA extraction kit (Hain
Lifescience GmbH, Nehren, Germany) according to the
manufacturer’s instructions. The 16S ribosomal DNA
(rDNA) was amplified using the primer pair 8F and
1492R [8]. The polymerase chain reaction conditions
and the subsequent steps of Sanger sequencing we used
were based on those described by Liu et al. [9]. The
resulting 16S rDNA sequence was checked using DE-
CIPHER (version 2.2.0; R Foundation for Statistical
Computing, Vienna, Austria) to verify that it was not a
chimera [10].
The procedure for molecular phylogenetic inference
was based on that described by Ku et al. [11]. Briefly,
the 16S rDNA sequence of the isolated strain was used
as the query for sequence similarity search against the
GenBank 16S rDNA sequence database. Highly similar
sequences representing closely related species were
Table 1 Timeline of treatment
Parameters Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Total white cell count 8.8 × 109/L Not done 8.5 × 109/L 10.8 × 109/L Not done Not done 9.4 × 109/L
Hemoglobin 6.6 g/dl Not done 5.1 g/dl 12.2 g/dl Not done Not done 10.6 g/dl
Antibiotics Intravenous cefuroxime 270 mg three times daily
Antibiotics Intravenous gentamicin 40 mg daily
Antibiotics Flucloxacillin suspension 5 ml four times daily
Antimalarial Artesunate 24 mg/24 hours
Malaria rapid diagnostic test Positive
Gram stain of broth Positive (gram-negative rods)
Blood culture isolate Positive
Hemotransfusion 240 ml/4 hours
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selected for phylogenetic inference. All sequences were
aligned using Multiple Sequence Comparison by Log-
Expectation (MUSCLE) [12], and the resulting multiple
sequence alignment was used to infer a maximum likeli-
hood phylogeny using PhyML (version 3.0) [13]. The
bootstrap support values were inferred based on resam-
pling 1000 iterations.
The isolated strain reported in this study was found to
be most similar to Pseudomonas oryzihabitans IAM 158
[GenBank accession NR_115005] with nucleotide se-
quence identity of 1455/1460 (99.7%). The molecular
phylogeny also indicated that the new sequence is clus-
tered with other P. oryzihabitans strains, which strongly
supports the findings displayed in Fig. 1. The purified bac-
terial strain has been assigned the strain name Agogo to
reflect its geographic origin and the sequence deposited in
the GenBank database [accession number KX812763].
Antimicrobial susceptibility testing was done on the iso-
lated bacteria using the Kirby-Bauer disk diffusion method
following Clinical Laboratory Standards Institute guidelines
[14]. The isolate was found to be susceptible to co-
trimoxazole, chloramphenicol, ciprofloxacin, and gentamicin
but resistant to ampicillin and cefuroxime. The rash on the
patient’s scalp and skin, as well as her temperature spikes,
resolved after continuous treatment with gentamicin, and
her condition improved clinically. She was discharged on
flucloxacillin and folic acid therapy 1 week after admission.
A final diagnosis of septicemia secondary to bacterial skin
infection with malaria coinfection was made.
Discussion
P. oryzihabitans is a rare bacterial isolate that has been
linked to meningitis, endocarditis, diabetes mellitus, and
infection with other organisms, especially in immuno-
compromised individuals [4, 15]. The pathogenicity of P.
oryzihabitans is still a subject of debate in the scientific
community, hence the need for adequate information to
enable clinicians and public health practitioners to man-
age episodes associated with this pathogen.
Although it might be difficult to determine to what
extent the severity of our patient’s illness was due to mal-
aria or sepsis, the presence of the rare pathogen P. oryziha-
bitans in the blood in our patient is of importance, being
the first such case reported from West Africa and only the
second in sub-Saharan Africa [15]. It is possible that the
pustular rashes provided an entry route for the bacteria
directly from the environment, and the patient eventually
progressed to sepsis. It is also possible that the child might
have been exposed through skin bites or minor abrasions,
either in the house or upon visiting her family’s farm. Our
patient’s case is similar to one reported in South Africa,
which occurred in a 4.7-year-old child who had been diag-
nosed with kwashiorkor, sepsis, and anemia [16]. Six cases
of skin and soft tissue infections caused by P.
Fig. 1 Maximum likelihood molecular phylogeny based on 16S ribosomal DNA sequences. The GenBank accession numbers are provided in
parentheses after the strain names. The newly isolated strain Agogo reported in this study is highlighted in bold. The levels of bootstrap support
are labeled above internal branches; only values greater than 60% are listed
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oryzihabitans have been reported in patients with a previ-
ous histories such as surgery, immunosuppression, dia-
betes mellitus, trauma, bites, and lactation [17]. Although
we did not perform an immunological immunodeficiency
test for our patient, the result of a screening test for HIV
antibody was negative, thus ruling out possible immuno-
deficiency disease associated with her illness.
An important feature we observed was the unique
microbiological characteristics of this bacterium and the
failure of the API to accurately identify the pathogen. The
biochemical properties of our isolate using the Analytical
Profile Index Non-Enterobacteriaceae (API NE) differed
from the usual reported cases of P. oryzihabitans by being
positive for gelatin hydrolysis and capric acid assimilation
and negative for mannose and maltose assimilation [18].
Bosshard et al. [19] observed the low sensitivity of the API
20NE and thus recommended the use of 16S ribosomal
ribonucleic acid (RNA) gene sequencing as an effective
means of identification of clinically relevant nonferment-
ing gram-negative bacilli.
Conclusions
Our report shows that a combination of conventional
and molecular technologies is the best approach to iden-
tifying Pseudomonas bacteria which may be implicated
in the clinical condition of this child.
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